Innovative medical technology Extend the length and width of life
Shorten treatment course- Reduce side effects
- Be the BNCT leader
公司理念
Innovative Treatment Options by AB-BNCT Patients Cured and Maintain Quality of Life
About Us
About HERON
Having A Global Vision, Settled In Taiwan
Heron Neutron Medical Corp., established in 2017 in Hsinchu, Taiwan. AB-BNCT (Accelerator-Based Boron Neutron Capture Therapy) technology were transfered from National Tsing Hua University and Industrial Technology Research Institute. Integrate talents to provide AB-BNCT total solutions, including accelerator system, target system, beam shaping assembly, treatment control system, treatment planning system, patients positioning system. In the past, radiation therapy mostly relied on foreign manufacturers to provide equipment and technology. HERON hopes to bring years of research results from Taiwan to global and obtain medical device certifications, allowing the domestic medical industry to advance into cutting-edge medical equipment. It will also promote the development of pharmaceutical industries and assist the government in promoting the development of Taiwan's precision health strategic industries.
Mission
Be a trusted global leader in the BNCT fieldBe a total solution provider of BNCT
Adhering to contribute to the welfare and expectations of life sciences, collaborate with the national strategy of developing precision medicine. HERON commercialized the 30 years of research results and bring to the medical field. By obtaining the medical device license and clinical applications, medical device technology could help more patients. Curing cancer, reducing the side effects of cancer treatment, and improving patients' quality of life. HERON expects to become AB-BNCT total solution provider with leading technology as well as professional service.
Vision
Committed to contributing to the human well-being and caring about life science
HERON is committed to commercializing the Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT) technology developed by National Tsing Hua University and the Industrial Technology Research Institute. Bringing together top talents in nuclear engineering and other fields in Taiwan, the aim is commercializing 30 years of research results into practical medical applications. By obtaining the medical device license and clinical trials, the medical technology could help more patients. Curing cancer, reducing the side effects of cancer treatment, and improving patients' quality of life.
Contact
If you have any questions, please contact us.
